Nutrients | Free Full-Text | Regulation of Gut Microbiota and Metabolic Endotoxemia with Dietary Factors
Frontiers | Intestinal Fibrosis and Gut Microbiota: Clues From Other Organs
Variation in Microbiome LPS Immunogenicity Contributes to Autoimmunity in Humans: Cell
Effects of cyanobacterial toxins on the human gastrointestinal tract and the mucosal innate immune system | Environmental Sciences Europe | Full Text
Lipid A and Bacterial Lipopolysaccharides, Gram-negative, endotoxins, lipo-chitooligosaccharides (Nod factors) - structure, occurrence, biochemistry and function
On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central r ... - Integrative Biology (RSC Publishing) DOI:10.1039/C5IB00158G
Inflammatory bowel disease therapeutic strategies by modulation of the microbiota: how and when to introduce pre-, pro-, syn-, or postbiotics? | American Journal of Physiology-Gastrointestinal and Liver Physiology
Frontiers | Like Cures Like: Pharmacological Activity of Anti-Inflammatory Lipopolysaccharides From Gut Microbiome
How To Inhibit Lipopolysaccharides (LPS), Lipoglycans, and Endotoxins — MyBioHack | Unlock Your Genetics
Nutrients | Free Full-Text | Intestinal Microbiota as a Contributor to Chronic Inflammation and Its Potential Modifications
PDF) Structure and Effects of Cyanobacterial Lipopolysaccharides
How To Inhibit Lipopolysaccharides (LPS), Lipoglycans, and Endotoxins — MyBioHack | Unlock Your Genetics
Unnarmicin D, an Anti-inflammatory Cyanobacterial Metabolite with δ and μ Opioid Binding Activity Discovered via a Pipeline Approach Designed to Target Neurotherapeutics | ACS Chemical Neuroscience
Jinzhi protects lipopolysaccharide-treated mice against mortality by repairing intestinal mucosal barrier damage and intestinal microecology - ScienceDirect
Frontiers | Gut Microbiota Dysbiosis and Increased Plasma LPS and TMAO Levels in Patients With Preeclampsia
Dysbiosis of Gram‑negative gut microbiota and the associated serum lipopolysaccharide exacerbates inflammation in type 2 diabetic patients with chronic kidney disease
Lipopolysaccharide in Inflammatory Bowel Diseases | Encyclopedia MDPI
New insights into lipopolysaccharide inactivation mechanisms in sepsis - ScienceDirect
Lipid A and Bacterial Lipopolysaccharides, Gram-negative, endotoxins, lipo-chitooligosaccharides (Nod factors) - structure, occurrence, biochemistry and function
Marine Drugs | Free Full-Text | Structure and Effects of Cyanobacterial Lipopolysaccharides
Frontiers | Stress Induces Endotoxemia and Low-Grade Inflammation by Increasing Barrier Permeability
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction | Gut
Leaky gut and lipopolysaccharides (LPS) / What's LPS / Macrophi Inc. | LPS material | innate immunity | R&D
Total Lipopolysaccharide from the Human Gut Microbiome Silences Toll-Like Receptor Signaling | mSystems
Toxins | Free Full-Text | Lipopolysaccharide from the Cyanobacterium Geitlerinema sp. Induces Neutrophil Infiltration and Lung Inflammation
How To Inhibit Lipopolysaccharides (LPS), Lipoglycans, and Endotoxins — MyBioHack | Unlock Your Genetics
